Suppr超能文献

以梗阻性黄疸为表现的肝细胞癌的管理

Management of hepatocellular carcinoma presenting as obstructive jaundice.

作者信息

Lau W Y, Leung J W, Li A K

机构信息

Department of Surgery, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories.

出版信息

Am J Surg. 1990 Sep;160(3):280-2. doi: 10.1016/s0002-9610(06)80023-1.

Abstract

Eleven (3%) of 340 patients with hepatocellular carcinoma (HCC) presented with obstructive jaundice. The tumor extensively infiltrated the major bile ducts in eight patients. Jaundice was relieved by endoscopic endoprosthesis in four patients, nasobiliary drainage in two patients, percutaneous transhepatic stenting in one patient, and surgical intubation in one patient. The survival interval of these eight patients (mean +/- SD) was 35 +/- 20 days. Three patients had tumor fragments in the common bile ducts. In two patients, major hepatic resection was done after initial tube decomposition of the biliary system. One patient remained tumor-free on follow-up at 24 months, and the other patient had recurrent tumor detected on follow-up at 17 months after surgery. The tumor was irresectable in the third patient. Multiple surgical and endoscopic procedures kept the bile duct patent for 17 months before the patient died of the disease. Not all patients who present with obstructive jaundice due to HCC are terminally ill. With proper management, good palliation and occasional cure are possible.

摘要

340例肝细胞癌(HCC)患者中有11例(3%)出现梗阻性黄疸。8例患者的肿瘤广泛浸润主要胆管。4例患者通过内镜内置假体使黄疸缓解,2例通过鼻胆管引流,1例通过经皮肝穿刺支架置入,1例通过手术插管。这8例患者的生存间隔(平均值±标准差)为35±20天。3例患者在胆总管中有肿瘤碎片。2例患者在胆道系统初始置管分解后进行了肝大部切除术。1例患者在24个月的随访中无肿瘤复发,另1例患者在术后17个月的随访中检测到肿瘤复发。第3例患者的肿瘤无法切除。多次手术和内镜操作使胆管保持通畅17个月,之后患者死于该疾病。并非所有因HCC出现梗阻性黄疸的患者都处于终末期。通过适当的管理,有可能实现良好的姑息治疗并偶尔治愈。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验